Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.
Patani H, Bunney TD, Thiyagarajan N, Norman RA, Ogg D, Breed J, Ashford P, Potterton A, Edwards M, Williams SV, Thomson GS, Pang CS, Knowles MA, Breeze AL, Orengo C, Phillips C, Katan M.
Patani H, et al. Among authors: edwards m.
Oncotarget. 2016 Apr 26;7(17):24252-68. doi: 10.18632/oncotarget.8132.
Oncotarget. 2016.
PMID: 26992226
Free PMC article.